Drug lookup
Drug reference

pethidine

Drug monograph

CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
incl. contraindicated
PREGNANCY
not curated
Top interactionssee all 12
  • AminophyllineContraindicatedTextbookKDT 7e · p227
  • ChlorpromazineSevereTextbook-citedKDT 7e · p950
  • DiazepamSevereTextbook-citedKDT 7e · p950
  • ImipramineSevereTextbook-citedKDT 7e · p950

Mechanism

Not yet extracted

Indications

analgesic (substitute of morphine)preanaesthetic medicationcontrol shivering (during recovery from anaesthesia or that attending i.v. infusions)preferred opioid analgesic during labour

Dosing

Adult
50–100 mg i.m., s.c. (may cause irritation, local fibrosis on repeated injection). Occasionally given orally or i.v.

Pharmacokinetics

Half-life
The plasma t½ of pethidine is 2–3 hours.
Bioavailability
Pethidine exhibits high first-pass metabolism.
Protein binding
Not specified in text
Metabolism
Pethidine is hydrolyzed.

Contraindications

  • Avoid in renal failure
  • renal failure patients given repeated doses (prone to experience excitatory effects)
  • patients receiving nonselective MAO inhibitors
  • patients receiving selective serotonin reuptake inhibitors (SSRI)

Side effects

Common
similar to morphine except less marked spasmodic action on smooth musclesless prominent miosisless prominent constipationless prominent urinary retentionsome atropinic effects (dry mouth, blurred vision, tachycardia)tachycardia (due to antimuscarinic action)less histamine releasesedativeeuphoriant
Serious
  • seizures (due to accumulation of nor-pethidine metabolite)
  • muscle twitching (due to accumulation of nor-pethidine metabolite)
  • excitatory effects in overdose (tremors, mydriasis, hyperreflexia, delirium, myoclonus and convulsions) due to accumulation of norpethidine
  • neonatal respiratory depression (significant even at equianalgesic doses)
  • local irritation and fibrosis on repeated i.m. or s.c. injection

Drug interactions

Aminophylline
Contraindicated
Textbook

Should not be mixed in the same infusion bottle/syringe.

Do not mix.

Source: KDT 7e · p227

Chlorpromazine
Severe
Textbook-cited

Severe sedation and respiratory depression

Avoid concurrent use

Source: KDT 7e · p950

Diazepam
Severe
Textbook-cited

Excessive sedation, respiratory depression, motor impairment.

Avoid concurrent use

Source: KDT 7e · p950

Imipramine
Severe
Textbook-cited

Severe sedation and respiratory depression

Avoid concurrent use

Source: KDT 7e · p950

Dapoxetine
Severe
Textbook

May produce the ‘serotonin syndrome’.

Avoid combining pethidine with SSRIs.

Source: KDT 7e · p475

Escitalopram + Clonazepam
Severe
Textbook

May produce the ‘serotonin syndrome’.

Avoid combining pethidine with SSRIs.

Source: KDT 7e · p475

Maoi Inhibitors
Severe
Textbook

Norpethidine (an excitant metabolite) is produced in excess, leading to excitement (tremors, mydriasis, hyperreflexia, delirium, myoclonus, convulsions).

Avoid combining pethidine with nonselective MAO inhibitors.

Source: KDT 7e · p475

Alprazolam
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Alvimopan
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amitriptyline
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Amobarbital
Severe
Database

Drug interaction classified as: synergy, metabolism

Source: DDInter

Amoxapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Related guidelines

Other Unclassified drugs

Ask House about pethidine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team